Skip to main content
NEXTURNBIOSCIENCE Co., LTD logo

NEXTURNBIOSCIENCE Co., LTD — Investor Relations & Filings

Ticker · 089140 ISIN · KR7089140008 KO Professional, scientific and technical activities
Filings indexed 486 across all filing types
Latest filing 2023-08-29 Legal Proceedings Report
Country KR South Korea
Listing KO 089140

About NEXTURNBIOSCIENCE Co., LTD

http://www.nexturn.co.kr

NEXTURNBIOSCIENCE Co., LTD. is a specialized manufacturer of Computer Numerical Control (CNC) automatic lathes, with a focus on Swiss-type models. The company develops and produces a range of machines, including both guide bush and non-guide bush types, utilizing proprietary technology. In addition to its core machinery business, NEXTURNBIOSCIENCE leverages its expertise in ultra-precision manufacturing to produce essential functional components. These high-quality parts serve critical applications across diverse sectors, including information technology (IT), construction equipment, and the medical industry, reflecting the company's expanding business scope.

Recent filings

Filing Released Lang Actions
주요사항보고서(소송등의제기)
Legal Proceedings Report Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities regarding the filing of a lawsuit (소송 등의 제기). It details a legal injunction request (가처분신청서) concerning the validity of convertible bond issuances. Since the document specifically addresses legal proceedings and litigation involving the company, it falls under the 'Legal Proceedings Report' category.
2023-08-29 Korean
반기보고서 (2023.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for Nexturn Bioscience, covering the period from January 1, 2023, to June 30, 2023. It contains detailed financial information, business operations, and management analysis, which fits the definition of an Interim/Quarterly Report (IR). H1 2023
2023-08-11 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Korea Exchange regarding a 'Capital Increase' (유상증자결정). It details the specifics of a third-party share issuance, including the number of shares, pricing, and purpose. Since it involves the issuance of new shares and changes to the company's capital structure, it falls under the 'Share Issue/Capital Change' category.
2023-08-10 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from Nexturn BioScience regarding a decision on a capital increase (유상증자결정). It details the issuance of new shares, the purpose of the funds, and the third-party allocation details. This type of filing is a standard regulatory disclosure for capital changes in the Korean market, which falls under the 'Share Issue/Capital Change' category.
2023-08-10 Korean
[기재정정]소액공모공시서류(지분증권)
Capital/Financing Update Classification · 98% confidence The document is a '소액공모공시서류' (Small-scale Public Offering Disclosure Document) filed by Nexturn Bioscience. It details a capital increase (issuance of new shares) through a third-party allocation method. In the context of financial filings, documents related to share issuance, capital changes, or public offerings of securities are classified under 'Share Issue/Capital Change' (SHA).
2023-08-10 Korean
[기재정정]소액공모실적보고서
Share Issue/Capital Change Classification · 100% confidence The document is a '소액공모실적보고서' (Small-scale Public Offering Results Report) filed with the Financial Supervisory Service (FSS) in South Korea. It details the results of a capital increase (issuance of new shares) and includes a correction (정정신고) regarding the listing date of the shares. Since this document reports on the actual issuance and results of a capital change/share issue, it falls under the 'Share Issue/Capital Change' category.
2023-08-10 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.